From: Balneotherapy for the treatment of post-COVID syndrome: a randomized controlled trial
Questionnaires/scales | post-balneotherapy vs. control group | one month after balneotherapy vs. control group | |||
---|---|---|---|---|---|
Beta-coefficient [95%CI] | FDR p-value | Beta-coefficient [95%CI] | FDR p-value | ||
PCFS | 0.131 [-0.165;0.427] | 0.448 | 0.16 [-0.281;0.313] | 0.916 | |
mMRC Dyspnoea Scale | 0.267 [-0.54;0.588] | 0.153 | 0.35 [0.05;0.65] | 0.069 | |
SF-36 Scale | |||||
Physical functioning | -5.873 [-12.24;0.501] | 0.718 | -6.187 [-12.24;-0.12] | 0.115 | |
Role limitations due to physical health | -10.634 [-19.04;-2.22] | 0.026 | -13.582 [-22.50;-4.66] | 0.011 | |
Role limitations due to emotional problems | -12.663 [-22.27;-3.04] | 0.023 | -9.258 [-18.84;0.33] | 0.124 | |
Energy/fatigue | -17.45 [-24.23;-10.66] | <0.0001 | -16.52 [-24.32;-8.71] | 0.00015 | |
Emotional well-being | -11.356 [-17.75;-4.96] | 0.003 | -3.598 [-10.77;3.578] | 0.535 | |
Social functioning | -16.513 [-25.55;-7.47] | <0.0001 | -15.956 [-25.43;-6.47] | 0.005 | |
Pain | -21.634 [-30.48;-12.78] | <0.0001 | -15.998 [-25.36;-6.63] | 0.005 | |
General health | -2.519 [-8.065;3.028] | 0.448 | -2.993 [-9599;3.614] | 0.555 | |
PSQI | 2.641 [1.15;4.12] | 0.003 | 1.096 [-0.466;2.657] | 0.311 | |
HADS | |||||
Anxiety | 1.72 [0.40;3.03] | 0.023 | -0.154 [-1.775;1.468] | 0.911 | |
Depression | 0.562 [-0.730;1.855] | 0.448 | 0.232 [-1.225;1.688] | 0.911 | |
MFE-30 | 1.168 [-5.235;7.570] | 0.718 | 0.785 [-6.113;7.681] | 0.911 | |
VAS | 1.625 [0.32;2.96] | 0.026 | 0.536 [-0.817;1.888] | 0.586 |